相关实验视频

Updated: Jun 17, 2025

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Sensitive Measurement of Mitophagy by Flow Cytometry Using the pH-dependent Fluorescent Reporter mt-Keima

Published on: August 12, 2018

在HSP70交互蛋白 (CHIP) 的C端与疾病相关的突变损害了其负面调节线粒细胞衰变的能力

Rebecca Earnshaw¹, Yu Tong Zhang¹, Gregory Heymann¹

¹Krembil Research Institute, Toronto Western Hospital, University Health Network, 60 Leonard Avenue, Toronto, ON M5T 0S8, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.

Neurobiology of disease

|August 8, 2024

概括

HSP70相互作用蛋白 (CHIP) 的C端通过降解PINK1.1来负面调节甲基. 失去CHIP会增强线粒,这表明与CHIP突变相关的神经退行性疾病的作用.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
遗传学是一个遗传学.

背景情况:

HSP70交互蛋白 (CHIP) 的C端是E3泛基因酶和HSP70共.
奇普基因突变会导致48型 (SCA48) 和SCAR16型脊髓小脑动症,但疾病机制尚不清楚.
线粒体功能障碍和线粒体功能障碍与神经退行有关,CHIP损失导致动物模型中的线粒体问题.

研究的目的:

阐明CHIP在线调节中的作用.
为了研究CHIP突变如何影响线粒.
探索CHIP,菌体和神经退行性疾病之间的联系.

主要方法:

研究了CHIP与PINK1/Parkin线粒途径的相互作用.
使用了体外分析和Caenorhabditis elegans模型.
分析了CHIP对PINK1降解和帕金转位的影响.
在CHIP缺陷和突变CHIP模型中检查了线粒细胞的水平.

主要成果:

CHIP作为PINK1/帕金介导线粒的负调节剂.
CHIP促进了PINK1的降解,并抑制了帕金氏线粒体转位,抑制了线粒体.
在C. elegans中,CHIP的丧失以PINK1和帕金因依赖的方式增强了线粒.
与疾病相关的CHIP突变在体外和体内调节了线粒细胞衰变.

结论:

通过准PINK1.1,CHIP可以负面控制菌体.
CHIP及其突变体对线粒细胞衰变的调节失调可能会导致神经退行.
对于与CHIP相关的神经退行性疾病来说,CHIP在线中的作用提供了潜在的治疗点.

关键词:

过敏症过敏症过敏症过敏症线粒细胞衰变 - - 线粒细胞衰变 (mitophagy) 是一种神经退行发生神经退行.在SCA48中,SCA48是SCA48中的一个.一个是STUB1一个是STUB1.

更多相关视频

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Translocation of Proteins into the Mitochondria

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

Export of Misfolded Proteins out of the ER

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...